4-[8-[4-[[5-(2-piperidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(2-pyrrolidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(trifluoromethyl)-3-pyridinyl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[2-(trifluoromethyl)pyrimidin-5-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine

C108H131F6N21O8 — CID 157409001

IUPAC4-[8-[4-[[5-(2-piperidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(2-pyrrolidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(trifluoromethyl)-3-pyridinyl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[2-(trifluoromethyl)pyrimidin-5-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine
SMILESFC(F)(F)c1cncc(CC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)c1.FC(F)(F)c1ncc(CC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)cn1.c1cnc2c(OC3CCC(Cc4ncc(CCN5CCCC5)cn4)CC3)cc(N3CCOCC3)cc2n1.c1cnc2c(OC3CCC(Cc4ncc(CCN5CCCCC5)cn4)CC3)cc(N3CCOCC3)cc2n1
InChIInChI=1S/C30H40N6O2.C29H38N6O2.C25H27F3N4O2.C24H26F3N5O2/c1-2-11-35(12-3-1)13-8-24-21-33-29(34-22-24)18-23-4-6-26(7-5-23)38-28-20-25(36-14-16-37-17-15-36)19-27-30(28)32-10-9-31-27;1-2-11-34(10-1)12-7-23-20-32-28(33-21-23)17-22-3-5-25(6-4-22)37-27-19-24(35-13-15-36-16-14-35)18-26-29(27)31-9-8-30-26;26-25(27,28)19-12-18(15-29-16-19)11-17-1-3-21(4-2-17)34-23-14-20(32-7-9-33-10-8-32)13-22-24(23)31-6-5-30-22;25-24(26,27)23-30-14-17(15-31-23)11-16-1-3-19(4-2-16)34-21-13-18(32-7-9-33-10-8-32)12-20-22(21)29-6-5-28-20/h9-10,19-23,26H,1-8,11-18H2;8-9,18-22,25H,1-7,10-17H2;5-6,12-17,21H,1-4,7-11H2;5-6,12-16,19H,1-4,7-11H2
InChIKeyBOBFNEMJIKMFHH-UHFFFAOYSA-N
MW1965.36 g/mol
LogP18.06
Rot. Bonds26

About 4-[8-[4-[[5-(2-piperidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(2-pyrrolidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(trifluoromethyl)-3-pyridinyl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[2-(trifluoromethyl)pyrimidin-5-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine

4-[8-[4-[[5-(2-piperidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(2-pyrrolidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(trifluoromethyl)-3-pyridinyl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[2-(trifluoromethyl)pyrimidin-5-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine (PubChem CID 157409001) has the molecular formula C108H131F6N21O8 and a molecular weight of 1965.36 g/mol. Its IUPAC name is 4-[8-[4-[[5-(2-piperidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(2-pyrrolidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(trifluoromethyl)-3-pyridinyl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[2-(trifluoromethyl)pyrimidin-5-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine.

Molecular Properties

Compound Name4-[8-[4-[[5-(2-piperidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(2-pyrrolidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(trifluoromethyl)-3-pyridinyl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[2-(trifluoromethyl)pyrimidin-5-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine
PubChem CID157409001
Molecular FormulaC108H131F6N21O8
Molecular Weight1965.36 g/mol
Exact Mass1964.04
IUPAC Name4-[8-[4-[[5-(2-piperidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(2-pyrrolidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(trifluoromethyl)-3-pyridinyl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[2-(trifluoromethyl)pyrimidin-5-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine
SMILESFC(F)(F)c1cncc(CC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)c1.FC(F)(F)c1ncc(CC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)cn1.c1cnc2c(OC3CCC(Cc4ncc(CCN5CCCC5)cn4)CC3)cc(N3CCOCC3)cc2n1.c1cnc2c(OC3CCC(Cc4ncc(CCN5CCCCC5)cn4)CC3)cc(N3CCOCC3)cc2n1
InChIInChI=1S/C30H40N6O2.C29H38N6O2.C25H27F3N4O2.C24H26F3N5O2/c1-2-11-35(12-3-1)13-8-24-21-33-29(34-22-24)18-23-4-6-26(7-5-23)38-28-20-25(36-14-16-37-17-15-36)19-27-30(28)32-10-9-31-27;1-2-11-34(10-1)12-7-23-20-32-28(33-21-23)17-22-3-5-25(6-4-22)37-27-19-24(35-13-15-36-16-14-35)18-26-29(27)31-9-8-30-26;26-25(27,28)19-12-18(15-29-16-19)11-17-1-3-21(4-2-17)34-23-14-20(32-7-9-33-10-8-32)13-22-24(23)31-6-5-30-22;25-24(26,27)23-30-14-17(15-31-23)11-16-1-3-19(4-2-16)34-21-13-18(32-7-9-33-10-8-32)12-20-22(21)29-6-5-28-20/h9-10,19-23,26H,1-8,11-18H2;8-9,18-22,25H,1-7,10-17H2;5-6,12-17,21H,1-4,7-11H2;5-6,12-16,19H,1-4,7-11H2
InChIKeyBOBFNEMJIKMFHH-UHFFFAOYSA-N
XLogP18.06
TPSA286.63 Ų
H-Bond Donors
H-Bond Acceptors29
Rotatable Bonds26
Heavy Atoms143
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001965.36
LogP ≤ 518.06
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1029

Analyze 4-[8-[4-[[5-(2-piperidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(2-pyrrolidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(trifluoromethyl)-3-pyridinyl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[2-(trifluoromethyl)pyrimidin-5-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-[8-[4-[[6-(trifluoromethyl)-3-pyridinyl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine
CID 157339164
2-[5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidin-2-yl]propan-2-ol
CID 161213116
4-[8-[4-[(2-methylpyrimidin-5-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine
CID 158858413
N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-2-(trifluoromethyl)pyrimidin-5-amine
CID 121335789
N,N-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidin-4-amine
CID 147864127
4-[8-[4-[(2-chloropyrimidin-4-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine
CID 157161500
4-[8-[4-[(2,5-dimethylpyrimidin-4-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine
CID 158204207
N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-6-(trifluoromethyl)pyridin-3-amine
CID 121335931
4-[8-[4-[(2-methoxy-3-pyridinyl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine
CID 159654436
N-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]acetamide
CID 121335573
5-ethyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine
CID 90454078
methyl 6-methyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidine-4-carboxylate
CID 157357366

Frequently Asked Questions

What is the IUPAC name of 4-[8-[4-[[5-(2-piperidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(2-pyrrolidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(trifluoromethyl)-3-pyridinyl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[2-(trifluoromethyl)pyrimidin-5-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine?
The IUPAC name of 4-[8-[4-[[5-(2-piperidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(2-pyrrolidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(trifluoromethyl)-3-pyridinyl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[2-(trifluoromethyl)pyrimidin-5-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine (CID 157409001) is 4-[8-[4-[[5-(2-piperidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(2-pyrrolidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(trifluoromethyl)-3-pyridinyl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[2-(trifluoromethyl)pyrimidin-5-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine.
What is the SMILES notation for 4-[8-[4-[[5-(2-piperidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(2-pyrrolidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(trifluoromethyl)-3-pyridinyl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[2-(trifluoromethyl)pyrimidin-5-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine?
The canonical SMILES for 4-[8-[4-[[5-(2-piperidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(2-pyrrolidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(trifluoromethyl)-3-pyridinyl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[2-(trifluoromethyl)pyrimidin-5-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine is FC(F)(F)c1cncc(CC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)c1.FC(F)(F)c1ncc(CC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)cn1.c1cnc2c(OC3CCC(Cc4ncc(CCN5CCCC5)cn4)CC3)cc(N3CCOCC3)cc2n1.c1cnc2c(OC3CCC(Cc4ncc(CCN5CCCCC5)cn4)CC3)cc(N3CCOCC3)cc2n1.
What is the InChIKey of 4-[8-[4-[[5-(2-piperidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(2-pyrrolidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(trifluoromethyl)-3-pyridinyl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[2-(trifluoromethyl)pyrimidin-5-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine?
The InChIKey is BOBFNEMJIKMFHH-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H40N6O2.C29H38N6O2.C25H27F3N4O2.C24H26F3N5O2/c1-2-11-35(12-3-1)13-8-24-21-33-29(34-22-24)18-23-4-6-26(7-5-23)38-28-20-25(36-14-16-37-17-15-36)19-27-30(28)32-10-9-31-27;1-2-11-34(10-1)12-7-23-20-32-28(33-21-23)17-22-3-5-25(6-4-22)37-27-19-24(35-13-15-36-16-14-35)18-26-29(27)31-9-8-30-26;26-25(27,28)19-12-18(15-29-16-19)11-17-1-3-21(4-2-17)34-23-14-20(32-7-9-33-10-8-32)13-22-24(23)31-6-5-30-22;25-24(26,27)23-30-14-17(15-31-23)11-16-1-3-19(4-2-16)34-21-13-18(32-7-9-33-10-8-32)12-20-22(21)29-6-5-28-20/h9-10,19-23,26H,1-8,11-18H2;8-9,18-22,25H,1-7,10-17H2;5-6,12-17,21H,1-4,7-11H2;5-6,12-16,19H,1-4,7-11H2.
What are the key properties of 4-[8-[4-[[5-(2-piperidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(2-pyrrolidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(trifluoromethyl)-3-pyridinyl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[2-(trifluoromethyl)pyrimidin-5-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine?
4-[8-[4-[[5-(2-piperidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(2-pyrrolidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(trifluoromethyl)-3-pyridinyl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[2-(trifluoromethyl)pyrimidin-5-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine has a molecular weight of 1965.36 g/mol, XLogP of 18.06, 26 rotatable bonds, 0 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[8-[4-[[5-(2-piperidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(2-pyrrolidin-1-ylethyl)pyrimidin-2-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[5-(trifluoromethyl)-3-pyridinyl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;4-[8-[4-[[2-(trifluoromethyl)pyrimidin-5-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine is sourced from PubChem (CID 157409001), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).